Sign in
8-K

Current Report

Spyre Therapeutics, Inc. Filed Acc 0001193125-23-209727

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d530241d8k.htm…